Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study details and core information appear unchanged between screenshots; any differences are limited to visual layout and formatting.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:22.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    The page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.
    Difference
    5%
    Check dated 2025-10-06T06:59:23.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Content updated to v3.1.0 and several drug-safety topics were removed; the page now emphasizes a newer version while reducing emphasis on health-safety sections.
    Difference
    0.6%
    Check dated 2025-09-29T03:42:30.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.3%
    Check dated 2025-09-14T21:40:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T17:56:18.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location in Ghent, Belgium, along with new resources related to Alpha-1 Antitrypsin Deficiency and chronic lung diseases. However, several previous entries, including specific location details and some related topics, have been removed.
    Difference
    6%
    Check dated 2025-08-31T12:18:44.000Z thumbnail image

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.